Content Navigation
( All
None )
Target and Pathway |
Top |
Target(s) |
Corticotropin-releasing factor receptor 1 (CRHR1) |
Target Info
|
Antagonist |
[2] |
References |
Top |
REF 1 |
ClinicalTrials.gov (NCT00481325) Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder. U.S. National Institutes of Health.
|
REF 2 |
Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008 Aug;33(9):2080-92.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.